41/76US=50 / Câncer
Huang RR, Itakura E, Wen DR, Cochran AJ. Tumor-related immune modulation of the regional lymph nodes. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 401-6. ISBN 978-1-60327-086-1.

TUMOR MODULACAO IMUNOLOGICA DOS GANGLIOS LINFATICOS REGIONAIS; IMUNIDADE; LINFONODOS; IMUNOSSUPRESSAO; MELANOMA; METASTASES

42/76US=50 / Câncer
Essner R. Reversal of immune suppression in sentinel lymph nodes. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 407-23. ISBN 978-1-60327-086-1.

REVERSAO DA IMUNOSSUPRESSAO EM LINFONODOS SENTINELAS; LINFONODOS SENTINELA; GRANULOCITOS-MACROFAGOS FACTOR ESTIMULADOR DE COLONIAS

43/76US=50 / Câncer
Wei S, Shreiner AB, Chang AE. Vaccine-primed lymph node cells in the adoptive immune suppression induced by established cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 425-32. ISBN 978-1-60327-086-1.

CELULAS T; IMUNOSSUPRESSAO; IMUNOTERAPIA ADOPTIVA; VACINAS; LINFONODOS

44/76US=50 / Câncer
Boonyaratanakornkit JB, Smith JE, Ghadially R. Cancer stem cells in metastatic melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 435-41. ISBN 978-1-60327-086-1.

CELULAS-TRONCO CANCEROSAS. MELANOMA METASTATICO; CELULAS-TRONCO DO CANCER; MELANOMA; METASTASE

45/76US=50 / Câncer
Kalani MA, Dalerge P, Clarke MF. Implications of cancer stem cells for tumor metastasis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 443-53. ISBN 978-1-60327-086-1.

IMPLICACOES DE CELULAS-TRONCO DO CANCER; METASTASE DE TUMOR; CELULAS-TRONCO DO CANCER; PROGNOSTICO DO PACIENTE; SOBREVIDA LIVRE DE METASTASES; MICROARRAY PERFIL DE EXPRESSAO GENICA; IMUNO-HISTOQUIMICA

46/76US=50 / Câncer
Li H, Tang DG. Prostate cancer stem cells and their involvement in metastasis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 455-61. ISBN 978-1-60327-086-1.

CANCER DE PROSTATA. CELULAS-TRONCO; CANCER DE PROSTATA; CELULAS-TRONCO DO CANCER; TUMORAIS CELULAS PROGENITORAS; METASTASE; CELULAS ESTAMINAIS METASTATICO

47/76US=50 / Câncer
Baehner FL. Estrogen receptor-positive breast cancer: tradicional prognostics, molecular pathology: a new breast cancer taxonomy and 21st century personalized prognostic and predictive assays. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 465-95. ISBN 978-1-60327-086-1.

PERFIL DE EXPRESSAO DE GENE; QRT-PCR; CANCER DE MAMA; CANCER DE MAMA TIPO BASAL; CANCER DA MAMA HER2 TIPO; CANCER DE MAMA TIPO LUMINAL; PROGNOSTICO; PREDITIVO

48/76US=50 / Câncer
Venna SS, Kashani-Sabet M. Molecular signatures in melanoma progression. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 497-509. ISBN 978-1-60327-086-1.

ASSINATURAS MOLECULARES EM PROGRESSAO MELANOMA; EXPRESSAO DO GENE; MARCADORES MOLECULARES; MELANOMAS FINOS; LINFONODO SENTINELA; METASTASE; FASE DE CRESCIMENTO RADIAL; FASE DE CRESCIMENTO VERTICAL

49/76US=50 / Câncer
Rugo HS, Lin AYJ. Targeted therapy for breast cancer: a focus on HER2/neu and antiangiogenic therapy. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 497-509. ISBN 978-1-60327-086-1.

TERAPIA-ALVO PARA CANCER DE MAMA; HER2/NEU E TERAPIA ANTIANGIOGENICA; CANCER DE MAMA METASTATICO; HER2/NEU; TRASTUZUMAB; LAPATINIB; BEVACIZUMAB; SUNITINIB; ANTIANGIOGENICO; TERAPIA-ALVO

50/76US=50 / Câncer
Ma WW, Jimeno A, Choti MA. Advances in the treatment of colorectal cancertargeting receptors of disease. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 523-32. ISBN 978-1-60327-086-1.

TRATAMENTO DO CANCER COLORECTAL; RECEPTORES DE SEGMENTACAO DE DOENCA; CANCER COLORRETAL; BEVACIZUMAB; CETUXIMAB; PANITUMUMAB; KRAS

51/76US=50 / Câncer
Ryan CJ. Development in the management of genitourinary malignancies: prostate cancer and renal cell carcinoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 533-44. ISBN 978-1-60327-086-1.

DOENCAS MALIGNAS DO APARELHO GENITURINARIO; CANCER DE PROSTATA; CARCINOMA DE CELULAS RENAIS; CASTRACAO-RESISTENTE O CANCER DE PROSTATA; ANDROGENIOS ADRENAIS; IMUNOTERAPIA; FASE II; ABIRATERONA; ATRASENTAN; BEVACIZUMAB; CALCITRIOL; QUIMIOTERAPIA; GVAX; IPILIMUMAB; IXABEPILONA; SATRAPLATIN; SIPULEUCEL-T; VEGF; SUNITINIB; SORAFENIB

52/76US=50 / Câncer
Karrim J, Dubey S. Advances in the treatment of lung cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 545-52. ISBN 978-1-60327-086-1.

TRATAMENTO DO CANCER DO PULMAO; NEOPLASIAS PULMONARES; QUIMIOTERAPIA; ADJUVANTE; MARCADORES BIOLOGICOS; ANGIOGENESE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INIBIDORES DA PROTEINA QUINASE; ANTICORPOS MONOCLONAIS; RADIOTERAPIA

53/76US=50 / Câncer
Schadendorf D. Pegylated interferons in the adjuvant treatment of melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 555-64. ISBN 978-1-60327-086-1.

TRATAMENTO ADJUVANTE DO MELANOMA. INTERFERON PEGUILADO; INTERFERON PEGUILADO; SOBREVIDA LIVRE DE RECIDIVA; SOBREVIDA GLOBAL; MELANOMA; EFEITOS IFN; AJCC ESTAGIO III

54/76US=50 / Câncer
Hauschild A, Kahler KC, Egberts F. Sorafenib, a multikinase inhibitor: results from clinical trials in melanoma patients. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 565-74. ISBN 978-1-60327-086-1.

SORAFENIB. INIBIDOR MULTIQUINASE; PACIENTES COM MELANOMA; MELANOMA; METASTASE; SORAFENIB; INIBIDORES MULTIQUINASE

55/76US=50 / Câncer
Chmielowski B, Ribas A. Targeting immunological synapse: new horizons in immunotherapy for cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 575-90. ISBN 978-1-60327-086-1.

SEGMENTACAO SINAPSE IMUNOLOGICA; IMUNOTERAPIA PARA O CANCER; IMUNOTERAPIA; SINAPSE IMUNOLOGICA; CTLA-4; AUTO-IMUNIDADE; MELANOMA; CANCER

56/76US=50 / Câncer
Garbe C, Weide B, Pflugfelder A, Eigentler T. Cutaneous metastases of melanoma: new treatment options. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 591-8. ISBN 978-1-60327-086-1.

METASTASES CUTANEAS DE MELANOMA. TRATAMENTO; MELANOMA; METASTASES CUTANEAS; INTERLEUCINA-2; IMIQUIMOD; BLEOMYCINE; TRATAMENTO INTRATUMORAL

57/76US=50 / Câncer
Tarhini AA, Kirkwood JM. Neoadjuvant approaches in melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 599-605. ISBN 978-1-60327-086-1.

NEO-ADJUVANTE EM MELANOMA; MELANOMA; NEOADJUVANTE; INTERFERON; IMUNOTERAPIA

58/76US=50 / Câncer
Agarwala SS. Implications of chemo/biochemotherapy in the treatment of metastatic melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 607-9. ISBN 978-1-60327-086-1.

QUIMIO/BIOQUIMIOTERAPIA. TRATAMENTO DO MELANOMA; IMUNOTERAPIA; QUIMIOTERAPIA; BIOQUIMIOTERAPIA; MELANOMA METASTATICO

59/76US=50 / Câncer
Leong SPL, Witte MH. Future perspectives for cancer metastasis: unanswered questions and unquestioned answers. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 613-6. ISBN 978-1-60327-086-1.

METASTASE DO CANCER; SISTEMA LINFOVASCULAR; IGNORANCIA

60/76US=30 / Radioterapia
Seegenschmiedt MH, Micke O, Heyd R. Heterotopic ossifications: general survery for all sites. In: Seegenschmiedt MH, Makoski H-B, Trott K-R, Brady LW. Radiotherapy for non-malignant disorders: comtemporary concepts and clinical results. New York: Springer - Verlag, 2008. p. 333-55. (Medical Radiology / Radiation Oncology) ISBN 978-3-540-62550-6.

OSSIFICACAO HETEROTOPICA

Primeira | Anterior | Próxima | Última